This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Interleukin 31 (IL31), C-His
Product Overview
BioVenic's Recombinant Canine Interleukin 31 (IL31), C-His is a recombinant protein expressed from Insect Cells. Its predicted molecular weight is 18.3 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Canine IL-31 is a four-helix bundle cytokine and a member of the gp130/IL-6 family. Produced primarily by activated Th2 cells, it signals through a heterodimeric receptor complex of IL-31RA and Oncostatin M receptor (OSMR). In dogs, IL-31 is a major driver of pruritus (itching) and skin inflammation. It is a validated clinical target for treating canine atopic dermatitis, with therapies like lokivetmab specifically designed to neutralize this cytokine to provide relief from chronic scratching and skin lesions.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.